Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Miskolc – page 6

182 clinical trials in Miskolc, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Miskolc at a glance
182
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

182 trials in Miskolc

Open in trial search

Cardiac failure

Not yet recruiting

Efficacy and Safety of Fixed‑Dose Combination of Dapagliflozin, Bisoprolol Fumarate, and Eplerenone vs Usual Care in Hospitalized Acute Heart Failure Patients

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Bisoprolol Fumarate
  • Sponsor:Institut De Recherches Internationales Servier IRIS

Angina pectoris

Not yet recruiting

A Study of Encoberminogene Rezmadenovec Gene Therapy for Patients with Refractory Angina Due to Coronary Artery Disease

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Flurpiradaz F 18
  • Sponsor:Xylocor Therapeutics Inc.

Anaemia of chronic disease

Not yet recruiting

Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Darbepoetin Alfa
  • Sponsor:Genexine Inc.

Magnetic resonance imaging

Not yet recruiting

Study on How Gadoquatrane Works and Its Safety in Children Undergoing MRI Scans

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Gadoquatrane
  • Sponsor:Bayer AG

Pneumonia

Not yet recruiting

Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cholesterol
  • Sponsor:Eagle Pharmaceuticals Inc.

Ischaemic stroke

Not yet recruiting

Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Redasemtide
  • Sponsor:Shionogi B.V.

Asthma

Not recruiting

Study on Long-Term Safety and Efficacy of Amlitelimab for Adults with Moderate to Severe Asthma

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dulaglutide
  • Sponsor:Eli Lilly & Co.

Rheumatoid arthritis

Not recruiting

Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Eli Lilly & Co.

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Olpasiran
  • Sponsor:Amgen Inc.

Colitis ulcerative+1

Not recruiting

A study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Balinatunfib
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Cardiac failure

Not recruiting

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Miskolc

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on breast cancer treatments, including studies for both triple-negative and ER+/HER2- variants. Research includes evaluation of new therapeutic combinations and prostate cancer treatments.

  • Advanced/Metastatic Breast Cancer
  • Triple-Negative Breast Cancer
  • Metastatic Castration-Resistant Prostate Cancer

Studies emphasize novel treatment approaches and combination therapies for improving patient outcomes.

02 Cardiovascular Studies

Comprehensive research into cardiovascular diseases and preventive treatments, including studies on stroke prevention and atherosclerosis management.

  • Heart Failure Management
  • Stroke Prevention
  • Deep Vein Thrombosis

Trials evaluate new medications for reducing cardiovascular events and improving patient outcomes.

03 Immunology and Inflammation

Investigations into treatments for inflammatory conditions and autoimmune disorders, with particular focus on dermatological and gastrointestinal diseases.

  • Atopic Dermatitis
  • Ulcerative Colitis
  • IgA Nephropathy

Research aims to develop targeted therapies for chronic inflammatory conditions.

04 Pediatric Medicine

Studies focusing on children's health, including respiratory infections, vaccine development, and treatment of childhood diseases.

  • Childhood Leukemia
  • Respiratory Syncytial Virus Prevention
  • Pediatric Ulcerative Colitis

Emphasis on developing safe and effective treatments for young patients.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.